ROSSARI — Rossari Biotech Balance Sheet
0.000.00%
- IN₹37.17bn
 - IN₹38.17bn
 - IN₹20.80bn
 
- 74
 - 25
 - 72
 - 61
 
Annual balance sheet for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st  | 2022 March 31st  | C2023 March 31st  | 2024 March 31st  | 2025 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IAS | IAS | IAS | IAS | IAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 890 | 640 | 1,503 | 708 | 1,051 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,612 | 3,263 | 3,676 | 4,625 | 5,156 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,547 | 6,093 | 7,214 | 8,448 | 10,431 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,682 | 3,480 | 3,267 | 3,619 | 4,937 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,613 | 12,567 | 13,676 | 15,722 | 18,962 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,502 | 2,947 | 3,485 | 4,247 | 5,366 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,526 | 4,516 | 4,524 | 5,244 | 7,107 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,088 | 8,052 | 9,152 | 10,477 | 11,854 | 
| Total Liabilities & Shareholders' Equity | 5,613 | 12,567 | 13,676 | 15,722 | 18,962 | 
| Total Common Shares Outstanding |